ArticlePharmaceutical biology2022
Deciphering the anti-filarial potential of bioactive compounds from
Article in Pharmaceutical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Ovicidal effect of eucalyptus wood vinegar on gastrointestinal nematodes' eggs from sheep.Veterinary world · 2025Article
- Plant polyphenols, terpenes, and terpenoids in oral health.Open medicine (Warsaw, Poland) · 2025Review
- HRAMS Proteomics Insights on the Anti-Filarial Effect ofProteomes · 2024Article
- Anti-filarial efficacy ofRSC advances · 2024Article
- Biosynthesis and characterization ofRSC advances · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextThe anthelminthic effect of
objectiveThis study evaluates the effect of MATERIAL AND
methodsThe ethanol extract of OS (EOS) leaves was tested for anti-filarial activity against
resultsThe EOS significantly inhibited the motility of adult female DISCUSSION AND
conclusionsThe effect of EOS and OS bioactive components on human filarial parasites can be further evaluated for the development of new anti-filarial formulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.